CT fractional flow reserve analysis safely cuts rates of invasive procedures without compromising safety
WEDNESDAY, April 24, 2024 (HealthDay News) — Computed tomography fractional flow reserve (CT-FFR) improves assessment of vessel blockages and reduces the number of stenosis patients referred for invasive revascularization procedures, according to a study published online April 4 in Radiology: Cardiothoracic Imaging.
Mangun K. Randhawa, M.D., from Massachusetts General Hospital and Harvard Medical School in Boston, and colleagues assessed three-month clinical outcomes among 284 patients with significant stenosis who underwent CT-FFR analysis of dual-source CT scans without heart rate control.
The researchers found that 56.3 percent had CT-FFR >0.80 (a negative result), 30.9 percent had a clearly positive result (≤0.75), and 12.6 percent had a borderline result between 0.76 and 0.80. Among patients with significant stenosis at coronary CT angiography, patients who underwent CT-FFR analysis had lower rates of invasive coronary angiography (74.5 versus 25.5 percent) and percutaneous coronary intervention (78.9 versus 21.1 percent).
“In patients with moderate narrowing or blockage of the arteries, there can be ambiguity about who would benefit from invasive testing and revascularization procedures,” Randhawa said in a statement. “CT-FFR helps us identify and select those patients who are most likely to benefit.”
Abstract/Full Text (subscription or payment may be required)
Socioeconomic Status Linked to Mortality After Acute Hip Fracture Surgery
Relapse Rare After Appendiceal Adenocarcinoma Resection
Disparities Identified in Home Health Care After Hip, Knee Replacement
Preoperative IV Iron Beneficial for Patients With Anemia Undergoing Cardiac Surgery
Recommendations Updated for Management of Anemia in CKD
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children
Robotic Arm-Assisted TKR Offers Similar Outcome to Conventional TKR
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors